Defunct Company
Total Trials
12
As Lead Sponsor
3
As Collaborator
9
Total Enrollment
1,893
NCT00002239
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
Phase: Phase 2
Role: Collaborator
Start: May 31, 1999
Completion: Not specified
NCT00022763
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
Start: Aug 31, 2001
NCT00089492
A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients
Start: Jul 31, 2004
Completion: Jun 30, 2006
NCT00233883
WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.
Phase: Phase 4
Start: Aug 31, 2005
Completion: Jul 31, 2006
NCT00326963
BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.
Start: Mar 31, 2006
Completion: May 31, 2007
NCT00337701
BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection
Start: Jun 30, 2006
Completion: Jan 31, 2007
NCT00488059
A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
Start: Jun 30, 2007
Completion: Oct 31, 2008